ABOUT US OUR EXPERTS NEWS SERVICES PUBLICATIONS CAREERS CONTACT HOME SERVICES HEALTHCARE & LIFE SCIENCES Healthcare One of the most defining developments in contemporary healthcare is the transition from activity-based to value-based delivery. Currently, many healthcare providers are remunerated based on their level of activity, which encourages focus on activities rather than improvements in patient health and life quality. The introduction of value-based payment schemes, which reward better patient outcomes, is an essential part in creating the healthcare providers of tomorrow, where patients’ quality of life is the main objective. The introduction of value-based healthcare will have a variety of implications for healthcare providers, payers, patients and the life sciences industry. One implication will be a change towards much more individualized patient care than the predominantly standardized treatment packages of today, especially for the growing number of chronically ill patients in need of long-term care. Continued development towards value-based healthcare will reveal further implications, which may disrupt current business models, as well as creating new possibilities. Life Sciences The life sciences industry is an increasingly important part of many national economies and plays a vital role in creating research-based economic growth. In order to uphold or grow strong clusters, governments and industry leaders are turning to national strategies for their life sciences clusters. These strategies shed light on solutions to challenges regarding attraction and retention of companies and skilled personnel. The conditions offered to perform R&D, and in particular clinical research, are central criteria when assessing the attractiveness of a jurisdiction. Our Healthcare & Life Sciences team helps clients adapt to new regulatory landscapes such as the ongoing transition from activity-based to value-based healthcare delivery and to stay attractive in the global competition for life sciences industry. Follow our work on LinkedIn WE HELP OUR CLIENTS WITH Value-Based Healthcare Models Design and Advocacy Life Sciences Strategies RECENT WORK Takeda Innovating for people living with a rare disease - why partnerships are key for the European OMP ecosystem The Suppliers of Parallel Imported Medicines in Finland Savings from parallel import of pharmaceuticals in Finland 2016-2020 Takeda The impact of plasma derived therapies in Europe View all Healthcare & Life Sciences publications CONTACT PERSON OUR OTHER SERVICES Climate & Sustainability Competition Dispute Support Energy Economics & Policy Financial Sector Greenland & The Arctic Healthcare & Life Sciences Internal Market IP Valuation & Transfer Pricing Postal & Delivery State Aid Tender & Auction Support TMT & Digital Transport COPENHAGEN Langebrogade 1 DK-1411 Copenhagen VAT number: DK25262441 CONTACT STOCKHOLM Lilla Nygatan 14 SE-111 28 Stockholm VAT number: SE516405041001 CONTACT HELSINKI Hämeentie 11 FIN-00530 Helsinki VAT number: FI29062416 CONTACT BRUSSELS Maison de la Radio Place Eugène Flagey 18 BE-1050 Brussels VAT number: BE0674684785 CONTACT Privacy Notice ALL RIGHTS RESERVED @ 2021 COPENHAGEN ECONOMICS FOLLOW US ON Hard facts. Clear stories COOKIES We use cookies to give you the best possible experience with our website. By using our site you agree with our cookie policy OK